United States · FDA National Drug Code directory
Lansoprazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-7350_03e97384-9aeb-4bf5-81ba-8d8a65eae03c
- Product NDC
- 0093-7350
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Lansoprazole
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091111 / 20270731
Source-listed ingredients
- LANSOPRAZOLE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0093-7350-56) · 0093-7350-56
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →